health
Small Phase 1b SER-155 Trial Reports Fewer Transplant Bloodstream Infections
A small phase 1b trial reported fewer bloodstream infections among donor stem-cell transplant recipients given SER-155 with vancomycin conditioning than among placebo recipients. The result is an early clinical signal from a small group, and the tested regimen combined both treatments.